Home Applications 761268 Application 761268
Type BLA
Sponsor CELLTRION Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761268 Vegzelma bevacizumab-adcd 351(k) Biosimilar Rx 2026-06-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VEGZELMA BEVACIZUMAB-ADCD INJECTABLE;INJECTION 100MG/4ML(25MG/ML) No No 002 VEGZELMA BEVACIZUMAB-ADCD INJECTABLE;INJECTION 400MG/16ML(25MG/ML) No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 ยท 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Vegzelma BEVACIZUMAB-ADCD CELLTRION USA, Inc. 4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe 2025-05-08 Warnings, Adverse reactions Exact identifier application number: BLA761268
Documents# Document, Submission type, Date table Document Submission type Date 72872 ORIG 2022-12-13 72170 ORIG 2022-09-29 72167 ORIG 2022-09-28